Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wasmuth

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
European Journal of Medical Research|November 15, 2008
Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine/cyclophosphamide/rituximab for low grade non-Hodgkin's lymphomaJ-C Wasmuth, H-P Fischer, T Sauerbruch, et al.
Der Internist|March 26, 2010
[Avascular necrosis of the bone after organ transplantation]M Vogel, K Strach, K Ehren, et al.
Infection|April 3, 2007
Repeated HCV-clearance in an HIV-infected patientM Vogel, J-C Wasmuth, J K Rockstroh, et al.
HIV Medicine|April 19, 2003
Changes of lymphocyte apoptosis associated with sequential introduction of highly active antiretroviral therapyJ-C Wasmuth, F Hackbarth, J K Rockstroh, et al.
Cellular and Molecular Neurobiology|February 1, 1996
Diurnal variation of corticotropin-releasing factor binding sites in the rat brain and pituitaryE Fuchs, J C Wasmuth, G Flügge, et al.
Journal of Chromatographic Science|January 30, 2010
Determination of nevirapine in plasma by GC-MSM Vogel, N Bertram, J C Wasmuth, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 9, 2000
Prediction of imminent complications in HIV-1-infected patients by markers of lymphocyte apoptosisJ C Wasmuth, K H Klein, F Hackbarth, et al.
European Journal of Medical Research|January 16, 2003
Enteric dysfunction in patients with asymptomatic HIV-infection versus patients with hypoproteinemia/hypalbuminemia and advanced HIV-infectionJ-C Wasmuth, K Schliefer, C Scheurlen, et al.
Infection|April 2, 2004
Safety, efficacy and development of resistance under the new protease inhibitor lopinavir/ritonavir: 48-week resultsE Voigt, J-C Wasmuth, M Vogel, et al.
European Journal of Clinical Pharmacology|August 11, 2007
Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicityJ-C Wasmuth, I Lambertz, E Voigt, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Medical Research|November 15, 2008
Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine/cyclophosphamide/rituximab for low grade non-Hodgkin's lymphomaJ-C Wasmuth, H-P Fischer, T Sauerbruch, et al.
Der Internist|March 26, 2010
[Avascular necrosis of the bone after organ transplantation]M Vogel, K Strach, K Ehren, et al.
Infection|April 3, 2007
Repeated HCV-clearance in an HIV-infected patientM Vogel, J-C Wasmuth, J K Rockstroh, et al.
HIV Medicine|April 19, 2003
Changes of lymphocyte apoptosis associated with sequential introduction of highly active antiretroviral therapyJ-C Wasmuth, F Hackbarth, J K Rockstroh, et al.
Cellular and Molecular Neurobiology|February 1, 1996
Diurnal variation of corticotropin-releasing factor binding sites in the rat brain and pituitaryE Fuchs, J C Wasmuth, G Flügge, et al.
Journal of Chromatographic Science|January 30, 2010
Determination of nevirapine in plasma by GC-MSM Vogel, N Bertram, J C Wasmuth, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 9, 2000
Prediction of imminent complications in HIV-1-infected patients by markers of lymphocyte apoptosisJ C Wasmuth, K H Klein, F Hackbarth, et al.
European Journal of Medical Research|January 16, 2003
Enteric dysfunction in patients with asymptomatic HIV-infection versus patients with hypoproteinemia/hypalbuminemia and advanced HIV-infectionJ-C Wasmuth, K Schliefer, C Scheurlen, et al.
Infection|April 2, 2004
Safety, efficacy and development of resistance under the new protease inhibitor lopinavir/ritonavir: 48-week resultsE Voigt, J-C Wasmuth, M Vogel, et al.
European Journal of Clinical Pharmacology|August 11, 2007
Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicityJ-C Wasmuth, I Lambertz, E Voigt, et al.
Pageof 6